Isidore Tepler

1.2k citations
8 papers · 947 · 1 hit paper · h-index 7

Impact in

  • Hematology top 5%
    • Platelet Disorders and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 10%
    • Cancer-related Molecular Pathways
    • Cancer Cells and Metastasis
    • Cytokine Signaling Pathways and Interactions

Papers in

    • Cancer Cells and Metastasis 2
    • Neutropenia and Cancer Infections 2
    • Hematopoietic Stem Cell Transplantation 2

Isidore Tepler

8 papers receiving 914 citations

Isidore Tepler's Hit Papers

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo 1987 · 634 citations
6340+13+26Years since publication200400600

Peers

Isidore Tepler
Comparison fields: 5 of 83
  • Hematology 182
  • Oncology 421
  • Biotechnology 91
  • Genetics 235
  • Immunology 168
Replace JN Ihle with:
JN Ihle United States
Kanji Hojo Japan
Siân Rizzo United Kingdom
Hong-Ji Xu United States
Nadia Gibelli Italy
Alessandra Gentile Italy
SA Cannistra United States
A Rosolen Italy
Ari Ristimäki Finland
RN Buick Canada
Isidore Tepler relative to JN Ihle United States JN Ihle's profile →
Citations per field
00.5×
JN Ihle · 1×
Citations per year

Countries citing papers authored by Isidore Tepler

Since Specialization
Citations

This map shows the geographic impact of Isidore Tepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isidore Tepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isidore Tepler more than expected).

Fields of papers citing papers by Isidore Tepler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isidore Tepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isidore Tepler. The network helps show where Isidore Tepler may publish in the future.

Co-authors

The 25 scholars most cited alongside Isidore Tepler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isidore Tepler Line = papers co-authored together Isidore Tepler links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
Hit paper breakdown →
1987634
2
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
1996219
3 199439
4 199422
5 199116
6 19938
7 19986
8 19933

About Isidore Tepler

Isidore Tepler is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Biotechnology, having authored 8 papers that have together received 947 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Neutropenia and Cancer Infections (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Cancer Research and Treatments (1 paper), Lung Cancer Treatments and Mutations (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Hematology (182 citations), Oncology (421 citations), Biotechnology (91 citations), Genetics (235 citations) and Immunology (168 citations). Isidore Tepler has collaborated with scholars based in United States. Frequent co-authors include William J. Muller, Philip Leder, Paul K. Pattengale, Eric Sinn, James A. Kaye, A. Y. Chang, Kathleen J. Beach, Marc B. Garnick, Joseph O. Moore and Laurence Elias. Their work appears in journals such as Cancer, British Journal of Haematology, Psycho-Oncology, Breast Cancer Research and Treatment and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact